Partnerships
Built tocollaborate.
Object Pharma welcomes discussions with pharmaceutical, biotechnology, academic and strategic partners interested in advancing neurotoxin science and therapeutic innovation.
Collaboration areas
P01
Therapeutic development
- ·Co-development
- ·Licensing
- ·Indication partnerships
P02
Scientific collaboration
- ·Translational research
- ·Academic collaborations
- ·Neurotoxin biology
P03
Development capabilities
- ·Process development
- ·Specialized neurotoxin expertise
- ·Selected ecosystem capabilities
P04
Commercial opportunities
- ·Regional partnerships
- ·Selected portfolio opportunities
- ·Medical-aesthetics opportunities through the appropriate Object company
Start the conversation
Contact business development.
Tell us about your organization and the opportunity you would like to explore. Our business development team reviews every inquiry.
